Links

Wikipedia: my background.

Press coverage: Sackner-Bernstein's move to the FDA.

Beta-blockers for heart failure: Sackner-Bernstein shows why the data supported the shift of these drugs from contraindicated to mandatory part of care.

Natrecor: Sackner-Bernstein's high impact publication showing evidence of harm.

Natrecor: Sackner-Bernstein's high impact publication Showing evidence of risk of death, with subsequent report as more data became available.

Natrecor: examples of the media coverage of Sackner-Bernstein's discoveries and analyses - as a single voice.

Parkinson's Discovery: first report of intracellular dopamine levels indopaminergic neurons of people with PD (Journal of Parkinson’s Disease).

Parkinson's Discovery: Peer-reviewed overview of the data showing how to conquer Parkinson’s (Journal of Neurology).

Parkinson's discovery: Sackner-Bernstein's explanation of the opportunity to transform millions of lives in a widely viewed patient site, earning amongst the highest views.

Parkinson's discovery: Sackner-Bernstein's interview with Worth Magazine Chairman, Jim McCann.

Parkinson's discovery: Sackner-Bernstein is part of Worth Magazine's "Worthy 100."

TEDxBrussels: Sackner-Bernstein explains how observing and acting on opportunities is easier with age.

Google Scholar page: Sackner-Bernstein's academic publications listed with impact. Note that the drop in activity correlates with his shift from academics to FDA, DARPA and drug development.